Navigation Links
Gallus Strengthens Biologics CMO Business with Acquisition of Laureate
Date:10/1/2013

St. Louis, Missouri (PRWEB) October 01, 2013

Gallus BioPharmaceuticals, LLC (Gallus), a leading biologics contract manufacturing organization (CMO), today announced its acquisition of Laureate Biopharmaceutical Services, Inc. (Laureate), a full service biologics CMO located in Princeton, New Jersey. This acquisition doubles Gallus’ process development (PD) and clinical drug substance manufacturing capacity, adds full protein characterization, testing and clinical fill-finish capability and offers a seamless development pathway for clients - from early stage PD and clinical manufacturing to commercial manufacturing.

United by a common mission to deliver outstanding clinical and commercial CMO services, the merged companies combine two organizations with proven track records and offer clients two Centers of Excellence for manufacturing therapeutic proteins using mammalian cell-culture: The Princeton site is a Center of Excellence for PD     solutions and manufacture of clinical-stage products, including fill-finish; the St. Louis site is a Center of Excellence for PD, clinical and commercial manufacture of biopharmaceutical products. Both sites are FDA approved, while the St. Louis site is also licensed by every major regulatory authority globally.

Gallus, a pure-play CMO, now has multiple clinical and commercial suites at the two sites, with 50L to 2,000L GMP single-use platforms from XcellerexTM and HyCloneTM in addition to 50L to 2,000L fixed and flexible stainless steel bioreactors and associated downstream purification for drug substance. Additionally, clinical fill-finish capabilities are part of the Princeton site. All of these services will be delivered by the combined team of 350 experienced and dedicated staff.

Michael A. Griffith, Laureate CEO, who will support the trans
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Gallus BioPharmaceuticals Enters Clinical Supply Agreement with Genzyme for Niemann-Pick Type B Disease
2. Gallus BioPharmaceuticals Announces Appointment of Senior Baxter Executive as Chief Commercial Officer
3. inVentiv Health Clinical Expands and Strengthens Executive Team with Three Strategic Appointments
4. SentoClone International AB Significantly Strengthens its Global Patent Portfolio Covering its Clinical Stage Sentinel Node-derived CD4 T-cell Cancer Therapy
5. BellBrook Labs Strengthens Ties with Cambio for Distribution of Transcreener HTS Assays in the UK
6. Cytos Biotechnology Strengthens Management Team
7. Delta Point Strengthens Management and Expands Consultancy Services with Addition of Former AstraZeneca Executive Michael Hickey
8. Molecular Detection Inc. Further Strengthens Patent Portfolio Broadly Covering Detection of Antibiotic-Resistant Bacteria
9. AMRI Strengthens Business Development and Marketing Groups
10. Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry Talent
11. CMC Biologics Strengthens its Innovative Biomanufacturing Technology Portfolio in Continuous Perfusion Systems
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... -- Research and Markets has announced the ... Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... with a focus on the Chinese situation. ... including definitions, classifications, applications and industry chain structure. The ...
(Date:9/22/2014)... , Sept. 22, 2014  WIRB-Copernicus Group ... ethical review services for clinical research, announced today ... (WIRB) has been reaccredited by the Association for ... which endeavors to improve safeguards for clinical research ... Donald A. Deieso , Ph.D., commented, "It is ...
(Date:9/21/2014)... University of Basel in Switzerland have succeeded in ... molecule for the first time. These extremely weak ... molecular properties and may also contribute to the ... results were published in the scientific journal ... the interaction between matter and light, is probably ...
(Date:9/20/2014)... 2014 MediVet America and ... groundbreaking surgery at the specialized Wolvega Horse Clinic. , ... flexor tendon was ruptured 90% and her deep digital ... a death sentence for a horse. , The clinic ... treatments . This revolutionary regenerative option for ruptured ...
Breaking Biology Technology:Global and Chinese Microcrystalline Cellulose Industry Report 2014 2Western IRB (WIRB) Awarded AAHRPP Reaccreditation 2Uncovering the forbidden side of molecules 2World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 2World’s first tendon replacement using Nanofiber and activated MediVet Stem Cell Fraction 3
... 8 Concentric Medical, Inc., the global leader in ... announced that it has completed a $15 million round ... venture capital firm New Enterprise Associates, Inc. (NEA) and ... at Concentric over the last several months made the ...
... Technologies, Inc. (Nasdaq: PMTI ), a ... cosmetic treatments, today announced the termination of its ... AB (OMX Nordic Exchange, Stockholm Mid Cap:QMED), a ... The international distribution agreement was originally entered ...
... N.J., Jan. 7 Par Pharmaceutical Companies, Inc. (NYSE: ... Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at ... The audio-only live webcast will be accessible through the J.P. ... the Par website at www.parpharm.com . A replay ...
Cached Biology Technology:Concentric Medical Closes on $15 Million Financing 2Palomar and Q-MED AB Terminate International Distribution Agreement 2Palomar and Q-MED AB Terminate International Distribution Agreement 3Palomar and Q-MED AB Terminate International Distribution Agreement 4Palomar and Q-MED AB Terminate International Distribution Agreement 5
(Date:9/22/2014)... their own "antifreeze" proteins to survive in the ... effect, researchers report: The protein-bound ice crystals that ... temperatures warm. , The finding is reported ... of Sciences . , "We discovered what appears ... of antifreeze proteins in Antarctic notothenioid fishes," said ...
(Date:9/22/2014)... institutions in the country selected by the National ... BEST Award a $2 million grant designed ... biomedical sciences graduate trainees to career opportunities that ... traditionally taken. , The award funds development of ... (iJOBs) program. It includes courses, seminars, shadowing, mentoring ...
(Date:9/22/2014)... this image burn in Khabarovsk Krai, a territory occupying the ... accompanied by plumes of smoke mark active fires. The smoke, ... towards the Sea of Okhotsk. Taiga and tundra ... inhabit the central depression, and deciduous forests are the natural ... in Russia in the summer, the 2014 wildfire season appears ...
Breaking Biology News(10 mins):Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 2Study: Antifreeze proteins in Antarctic fishes prevent freezingand melting 3Rutgers receives $2 million grant to prepare biomedical students for roles in industry 2Rutgers receives $2 million grant to prepare biomedical students for roles in industry 3
... it comes to gene sequencing and personalized medicine for cancer, ... are relatively easy to target with drugs and plenty of ... University of Michigan Comprehensive Cancer Center researchers assess the complete ... are acting up in a particular tumor. They go on ...
... Athens, Ga. When Li Tan approached his colleagues at ... collected, they initially seemed convinced that his experiment had become ... Tan was examining some of the sugars, proteins and ... structural support and protection that allow plants to grow. Yet ...
... 5 February 2013 EMBO and the Federation of European ... Institut Curie in Paris, France, as the winner of the ... Professor Almouzni has been recognized for her outstanding contributions to ... in promoting epigenetics in Europe, and her active role in ...
Cached Biology News:Study finds potential to match tumors with known cancer drugs 2Study finds potential to match tumors with known cancer drugs 3Newly discovered plant structure may lead to improved biofuel processing 2Newly discovered plant structure may lead to improved biofuel processing 3Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award 2Geneviève Almouzni to receive the 2013 FEBS | EMBO Women in Science Award 3
1, 2 or 8 PreMixes are included as part of the FailSafe™ PCR System....
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
Endomorphin-2. Cross reactivity: Endomorphin-1 3%, Met-enkephalin <0.03%, Leu-enkephalin <0.01% and beta-Endorphin <0.01%....
... Sf-900 II SFM.Sf21 Cells ... Spodoptera frugiperda (Fall Armyworm) ... The Sf21 cells are ... culture in Sf-900 II ...
Biology Products: